Our development framework connects material science, formulation, precision mold design and controlled processing to move a microneedle concept toward a reproducible prototype.
Formulation development
Polymer matrix selection, rheology adjustment, active compatibility and dissolution planning.
Active embedding
Process design to improve payload distribution across the needle tips or selected matrix zones.
Mold customization
Needle height, density, array, base geometry and patch shape engineered to the project brief.
Low-temperature drying
Process-window development intended to reduce unnecessary thermal stress on temperature-sensitive actives.
Controlled release R&D
Matrix and structural experiments for project-specific dissolution, release or multi-phase concepts.
Scale translation
Critical parameters are documented through samples and pilot work to support an appropriate next stage.
Evidence before claims
Performance depends on the exact formula, needle design, process and use conditions. We define project-specific acceptance criteria rather than applying a generic efficacy claim. Available workstreams can include dimensional inspection, appearance and integrity checks, dissolution observations, active-content testing through qualified methods, packaging compatibility, stability planning and third-party test coordination.
Designed for collaborative development
Brand and formulation teams receive a clear technical brief. Pharmaceutical and biotech teams can engage at the non-confidential feasibility stage, then move to controlled data exchange under an agreed confidentiality process. Universities and laboratories can request samples aligned with a study design, instrument setup or proof-of-concept objective.